Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NRL001 (Methoxamine) Dose-Finding in Healthy Volunteers
NCT06593743Phase 1Completed
- Sponsor
- Norgine
- Start
- Dec 2002
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of Methoxamine in fecal incontinence (FI) (4 arms), sponsored by Norgine. Primary endpoint: Mean Anal Resting Pressure at 6 hours. Started Dec 2002; status: completed.
02
Drugs
Methoxamine
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT06593743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06593743.